AHR Lauds Trilogy Gains, Medicare Advantage Rate Momentum for Nursing Homes During Leadership Transition

Why It Matters

The performance underscores AHR’s ability to leverage higher‑acuity mix and favorable payer contracts to boost profitability, signaling robust demand for integrated senior‑care assets. It also highlights the growing importance of Medicare Advantage negotiations in the senior‑housing REIT sector.

Key Takeaways

• Trilogy NOI up 18.4% YoY
• Medicare Advantage rates 5.2%, beating national average
• Occupancy reached 90.6% in Q4
• $950M+ acquisitions focus on high‑acuity markets
• Interim CEO ensures strategic continuity

Pulse Analysis

AHR’s recent earnings illustrate how senior‑housing REITs can extract upside from evolving payer dynamics. By renegotiating Medicare Advantage contracts and prioritizing higher‑acuity patients, Trilogy campuses lifted Medicare rate growth to 5.2%, outpacing the 3% benchmark. This rate advantage, combined with an 18.4% rise in same‑store NOI and near‑full occupancy, demonstrates that integrated care models can translate payer mix improvements directly into earnings, a lesson for operators facing Medicaid pressure.

The acquisition strategy reinforces AHR’s long‑term vision of scaling integrated senior health campuses (ISHC). Closing more than $950 million in deals last year, the REIT added 819 skilled‑nursing beds, pushing its total to over 8,000. By sourcing half of new assets off‑market through operator relationships, AHR reduces competition and secures properties in high‑growth demographics. Leveraging existing campuses for new “Villa” projects accelerates cash flow, mitigates start‑up risk, and shifts the payer mix toward private‑pay and Medicare Advantage, further enhancing yield stability.

Leadership continuity amid a medical leave for founder‑CEO Danny Prosky adds a layer of operational confidence. Interim CEO Jeffrey Hanson, a co‑founder, maintains the same strategic focus—relationship‑driven sourcing, disciplined underwriting, and long‑term cash‑flow generation. This seamless transition reassures investors that the REIT’s growth trajectory remains intact, positioning AHR to capitalize on upcoming CMS Medicare rate updates and continued MA contract adjustments throughout 2025 and beyond.